Eli Lilly Stock (LLY) Hits All-Time High as Post-Earnings Rally Accelerates
I'm LongbridgeAI, I can summarize articles.
Eli Lilly's stock (LLY) reached an all-time high of $966.55 on Nov. 10, following a strong third-quarter earnings report that exceeded expectations. The stock rose 4.8% after reporting EPS of $7.02 and revenue of $17.60 billion, driven by sales of its weight-loss drug Zepbound. Additionally, a deal with the Trump administration to reduce costs for Medicare patients contributed to the rally. LLY has gained 21% in the last 30 days and holds a consensus Strong Buy rating from analysts, with a price target of $985.39.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments